EUVIMEDEUVIMED entdecken
Open Access

Coproporphyrin I as an in vitro fluorescent probe to measure OATP1B1 transport activity

Elizabeth R Hayden, Vivian Xu, Lisa Krotz, Jessica J Hockler, Benjamin D Kaczynski, Jason A Sprowl

Drug Metabolism and Disposition · 2025

DOI: 10.1016/j.dmd.2025.100073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Elizabeth R Hayden und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, …. Hauptthemen laut MEDLINE: Coproporphyrins, Liver-Specific Organic Anion Transporter 1, Fluorescent Dyes, Organic Anion Transporters. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIDCD NIH HHS, NIH National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The organic anion transporting polypeptide 1B1 (OATP1B1) is a major pharmacologically relevant hepatic uptake transporter that mediates the clearance of many drugs. The OATP1B1 substrate coproporphyrin I (CPI) has been continually shown to be a reliable and specific clinical biomarker of transport activity. These investigations, and others that have characterized OATP1B activity and transport kinetics, have largely relied on expensive, time-consuming, and nonfluorescent methods to detect CPI, such as liquid chromatography-tandem mass spectrometry. In consideration of porphyrin fluorescent properties, we hypothesized that CPI fluorescence can serve as a marker of OATP1B1 transport activity. Cellular accumulation of CPI specifically due to OATP1B1 was measured via fluorescence in the presence or absence of various Food and Drug Administration-approved tyrosine kinase inhibitors (TKIs). Our findings indicate that CPI fluorescence is an appropriate marker of OATP1B1 in vitro activity in overexpressing HEK293 cells. It was also observed that nilotinib, a TKI previously reported as an OATP1B1 inhibitor, could reduce 50% of CPI uptake at a concentration of 1.0 ± 0.5 μM. Using CPI and 8-(2-[Fluoresceinyl]aminoethylthio) adenosine- 3', 5'- cyclic monophosphate, 15 other TKIs were identified as potential OATP1B1 inhibitors, including tivozanib, which was observed to inhibit 50% of OATP1B1 activity at 4.0 ± 2.0 μM. Overall, our findings provide evidence to show that CPI fluorescence can be used as a method to assess OATP1B1-mediated transport in vitro and investigate the potential for drug-drug interactions. SIGNIFICANCE STATEMENT: This paper outlines a methodology for assessing coproporphyrin I accumulation in vitro specific to organic anion transporting polypeptide 1B1 (OATP1B1)-mediated transport. Coproporphyrin I is a reported sensitive clinical biomarker of OATP1B1 activity, and its fluorescent properties serve to provide a substrate with translational relevance in measuring drug-drug interactions in vitro with a low cost and time requirement. This method confirms nilotinib as an effective OATP1B1 inhibitor and identifies new inhibitors that can potentially promote life-threatening drug interactions using a clinically relevant biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoproporphyrinsLiver-Specific Organic Anion Transporter 1Fluorescent DyesOrganic Anion TransportersHumansHEK293 CellsBiological TransportPyrimidines

Stichwörter der Autor:innen

Coproporphyrin IDrug transportDrug-drug interactionsHepatic transportOATP1B1Tyrosine kinase inhibitors

Substanzen

CoproporphyrinsLiver-Specific Organic Anion Transporter 1coproporphyrin ISLCO1B1 protein, humanFluorescent DyesOrganic Anion TransportersPyrimidines

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York.
  • Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York. Electronic address: jasonspr@buffalo.edu.

Förderung

  • NIGMS NIH HHS
  • NIDCD NIH HHS
  • NIH National Institute of General Medical Sciences
  • National Institute on Deafness and Other Communication Disorders
  • National Science Foundation

Zitieren

APA

Hayden, E. R., Xu, V., Krotz, L., Hockler, J. J., Kaczynski, B. D., & Sprowl, J. A. (2025). Coproporphyrin I as an in vitro fluorescent probe to measure OATP1B1 transport activity. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100073

Vancouver

Hayden ER, Xu V, Krotz L, Hockler JJ, Kaczynski BD, Sprowl JA. Coproporphyrin I as an in vitro fluorescent probe to measure OATP1B1 transport activity. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100073

BibTeX
@article{Hayden2025,
  author = {Hayden, Elizabeth R and Xu, Vivian and Krotz, Lisa and Hockler, Jessica J and Kaczynski, Benjamin D and Sprowl, Jason A},
  title = {Coproporphyrin I as an in vitro fluorescent probe to measure OATP1B1 transport activity},
  journal = {Drug Metabolism and Disposition},
  year = {2025},
  doi = {10.1016/j.dmd.2025.100073}
}
Kostenlos starten →